News
DelveInsight's Rheumatoid Arthritis Pipeline report depicts a robust space with 75+ active players working to develop 80+ ...
3d
Onlymyhealth on MSNCan Taking Steroids Give You Acne? Causes, Symptoms, Treatment and PreventionCan taking steroids cause acne Read ahead to know about steroid-induced acne causes symptoms treatment and prevention with ...
To see whether a higher MTX dose resulted in higher steroid-free remission rates ... The research was funded by the Dutch Arthritis Society and Rheumatology Sint Maartenskliniek. Tedeschi has ...
1d
News Medical on MSNFirst of its kind study for children with arthritis reveals possible new disease targetsResearchers have been able to see what happens in inflamed joints of children with arthritis, giving insight into why treatments affect children differently.
Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial ...
GlobalData on MSN15h
Novartis’ Cosentyx shows no benefit in Phase III GCA trialNovartis’ Cosentyx (secukinumab) has failed to show any benefit in the Phase III study in adults with newly diagnosed or ...
NVS' Cosentyx fails to meet its primary goal in a phase III study for giant cell arteritis, despite favorable safety data.
Dr. Kimberly Trotter distilled four high-impact disease clusters—gout, rheumatoid arthritis (RA), systemic lupus ...
4d
Everyday Health on MSNHow Rheumatoid Arthritis Affects the SkinRA primarily affects the joints, but it can also cause symptoms in other areas of the body, such as the skin. Learn how RA ...
Novartis' blockbuster immunology drug Cosentyx has disappointed in a phase 3 trial involving patients with giant cell ...
Novartis announced top-line results from the phase III GCAptAIN study evaluating Cosentyx (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA). In the study, Cosentyx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results